Revisiting multiple models of progression of β-cell loss of function in type 1 diabetes: Significance for prevention and cure.
Type 1 diabetes (T1D) results from a chronic autoimmune process that leads to β-cell destruction and exogenous insulin dependence. The natural history of T1D proposed by Eisenbarth suggested six relatively independent stages over the course of the entire disease process, which was considered to be linear and chronic. Based on this classical theory, immunotherapies aim to prevent or reverse all these periods of β-cell loss. Over the past 30 years, much novel information about the pathogenesis of T1D proved that there are complex metabolic changes occurring throughout the entire disease process. Therefore, new possible models for the natural history of the disease have been proposed; these models, in turn, may help facilitate fresh avenues for the prevention and cure of T1D. Herein, we briefly review recent findings in this field of research, with the aim of providing a better theoretical basis for clinical practice.
['Li|Xia|X|', 'Cheng|Jin|J|', 'Zhou|Zhiguang|Z|']
D001786:Blood Glucose D002096:C-Peptide D003922:Diabetes Mellitus, Type 1 D018450:Disease Progression D020022:Genetic Predisposition to Disease D006801:Humans D007328:Insulin D000078790:Insulin Secretion D050417:Insulin-Secreting Cells D008954:Models, Biological D013997:Time Factors
β-cell autoimmunity immunotherapy 1型糖尿病 type 1 diabetes mellitus β细胞 免疫治疗 自身免疫